194 related articles for article (PubMed ID: 12036455)
1. Dexamethasone-resistant human Pre-B leukemia 697 cell line evolving elevation of intracellular glutathione level: an additional resistance mechanism.
Inoue H; Takemura H; Kawai Y; Yoshida A; Ueda T; Miyashita T
Jpn J Cancer Res; 2002 May; 93(5):582-90. PubMed ID: 12036455
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of glutathione synthesis overcomes Bcl-2-mediated topoisomerase inhibitor resistance and induces nonapoptotic cell death via mitochondrial-independent pathway.
Yoshida A; Takemura H; Inoue H; Miyashita T; Ueda T
Cancer Res; 2006 Jun; 66(11):5772-80. PubMed ID: 16740716
[TBL] [Abstract][Full Text] [Related]
3. A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells.
Friesen C; Kiess Y; Debatin KM
Cell Death Differ; 2004 Jul; 11 Suppl 1():S73-85. PubMed ID: 15105835
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.
Seo T; Urasaki Y; Takemura H; Ueda T
Anticancer Res; 2005; 25(2A):991-8. PubMed ID: 15868938
[TBL] [Abstract][Full Text] [Related]
5. Lack of mitochondrial depolarization by oxidative stress is associated with resistance to buthionine sulfoximine in acute lymphoblastic leukemia cells.
Goto H; Yanagimachi M; Kajiwara R; Kuroki F; Yokota S
Leuk Res; 2007 Sep; 31(9):1293-301. PubMed ID: 17306873
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members.
Laane E; Panaretakis T; Pokrovskaja K; Buentke E; Corcoran M; Söderhäll S; Heyman M; Mazur J; Zhivotovsky B; Porwit A; Grandér D
Haematologica; 2007 Nov; 92(11):1460-9. PubMed ID: 18024393
[TBL] [Abstract][Full Text] [Related]
7. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
8. Development of resistance to glutathione depletion-induced cell death in CC531 colon carcinoma cells: association with increased expression of bcl-2.
Vahrmeijer AL; Hoetelmans RW; Mulder GJ; Schutrups J; van Vlierberghe RL; van de Velde CJ; van Dierendonck JH
Biochem Pharmacol; 2000 Jun; 59(12):1557-62. PubMed ID: 10799652
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.
Miyashita T; Reed JC
Blood; 1993 Jan; 81(1):151-7. PubMed ID: 8417786
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells.
Takemura H; Urasaki Y; Yoshida A; Fukushima T; Ueda T
Cancer Res; 2001 Jan; 61(1):172-7. PubMed ID: 11196156
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 overexpression is associated with resistance to dexamethasone, but not melphalan, in multiple myeloma cells.
Gazitt Y; Fey V; Thomas C; Alvarez R
Int J Oncol; 1998 Aug; 13(2):397-405. PubMed ID: 9664139
[TBL] [Abstract][Full Text] [Related]
12. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
Medh RD; Saeed MF; Johnson BH; Thompson EB
Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
[TBL] [Abstract][Full Text] [Related]
13. Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependent.
Evens AM; Prachand S; Shi B; Paniaqua M; Gordon LI; Gartenhaus RB
Clin Cancer Res; 2004 Feb; 10(4):1481-91. PubMed ID: 14977852
[TBL] [Abstract][Full Text] [Related]
14. Glutathione depletion up-regulates Bcl-2 in BSO-resistant cells.
D'Alessio M; Cerella C; Amici C; Pesce C; Coppola S; Fanelli C; De Nicola M; Cristofanon S; Clavarino G; Bergamaschi A; Magrini A; Gualandi G; Ghibelli L
FASEB J; 2004 Oct; 18(13):1609-11. PubMed ID: 15289449
[TBL] [Abstract][Full Text] [Related]
15. Differential Expression of Bcl-2 Family Proteins Determines the Sensitivity of Human Follicular Lymphoma Cells to Dexamethasone-mediated and Anti-BCR-mediated Apoptosis.
Adem J; Ropponen A; Eeva J; Eray M; Nuutinen U; Pelkonen J
J Immunother; 2016 Jan; 39(1):8-14. PubMed ID: 26641257
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
[TBL] [Abstract][Full Text] [Related]
17. Regulation of apoptosis/necrosis execution in cadmium-treated human promonocytic cells under different forms of oxidative stress.
Sancho P; Fernández C; Yuste VJ; Amrán D; Ramos AM; de Blas E; Susin SA; Aller P
Apoptosis; 2006 May; 11(5):673-86. PubMed ID: 16532269
[TBL] [Abstract][Full Text] [Related]
18. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
Han SS; Han S; Kamberos NL
Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase M1 inhibits dexamethasone-induced apoptosis in association with the suppression of Bim through dual mechanisms in a lymphoblastic leukemia cell line.
Hosono N; Kishi S; Iho S; Urasaki Y; Yoshida A; Kurooka H; Yokota Y; Ueda T
Cancer Sci; 2010 Mar; 101(3):767-73. PubMed ID: 20067466
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone?
Weller M; Schmidt C; Roth W; Dichgans J
Neurology; 1997 Jun; 48(6):1704-9. PubMed ID: 9191791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]